Equities research analysts expect that Cardinal Health Inc (NYSE:CAH) will post $1.58 earnings per share for the current quarter, according to Zacks Investment Research. Eight analysts have issued estimates for Cardinal Health’s earnings, with estimates ranging from $1.42 to $1.78. Cardinal Health posted earnings per share of $1.53 in the same quarter last year, which would suggest a positive year-over-year growth rate of 3.3%. The company is scheduled to announce its next quarterly earnings report on Monday, May 7th.

On average, analysts expect that Cardinal Health will report full year earnings of $5.11 per share for the current fiscal year, with EPS estimates ranging from $4.90 to $5.43. For the next year, analysts expect that the firm will post earnings of $5.86 per share, with EPS estimates ranging from $5.35 to $6.51. Zacks’ earnings per share averages are an average based on a survey of research firms that follow Cardinal Health.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, February 8th. The company reported $1.31 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.14 by $0.17. Cardinal Health had a net margin of 1.37% and a return on equity of 24.81%. The firm had revenue of $35.19 billion during the quarter, compared to analysts’ expectations of $34.63 billion. During the same period last year, the company posted $1.34 EPS. The company’s quarterly revenue was up 6.1% compared to the same quarter last year.

CAH has been the subject of several research analyst reports. Mizuho set a $70.00 target price on shares of Cardinal Health and gave the stock a “hold” rating in a research report on Tuesday, October 24th. Jefferies Group dropped their target price on shares of Cardinal Health from $77.00 to $67.00 and set a “hold” rating for the company in a research report on Tuesday, November 7th. Zacks Investment Research raised shares of Cardinal Health from a “sell” rating to a “hold” rating in a research report on Wednesday, November 8th. Argus cut shares of Cardinal Health from a “buy” rating to a “hold” rating in a research report on Wednesday, November 15th. Finally, Morgan Stanley cut shares of Cardinal Health from an “equal weight” rating to an “underweight” rating in a research report on Monday, November 20th. Two equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and five have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $75.84.

In related news, CEO Michael C. Kaufmann sold 18,586 shares of Cardinal Health stock in a transaction dated Monday, January 22nd. The shares were sold at an average price of $73.90, for a total transaction of $1,373,505.40. Following the completion of the transaction, the chief executive officer now directly owns 211,849 shares of the company’s stock, valued at approximately $15,655,641.10. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 0.97% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Pzena Investment Management LLC grew its stake in shares of Cardinal Health by 8.0% in the fourth quarter. Pzena Investment Management LLC now owns 1,950,460 shares of the company’s stock worth $119,505,000 after acquiring an additional 143,938 shares during the period. AI Financial Services LLC bought a new stake in shares of Cardinal Health in the fourth quarter worth approximately $1,637,000. Norinchukin Bank The grew its stake in shares of Cardinal Health by 7.4% in the fourth quarter. Norinchukin Bank The now owns 26,003 shares of the company’s stock worth $1,593,000 after acquiring an additional 1,789 shares during the period. American International Group Inc. grew its stake in shares of Cardinal Health by 5,859.3% in the fourth quarter. American International Group Inc. now owns 7,969,384 shares of the company’s stock worth $488,284,000 after acquiring an additional 7,835,654 shares during the period. Finally, TCW Group Inc. grew its stake in shares of Cardinal Health by 11.5% in the fourth quarter. TCW Group Inc. now owns 1,537,591 shares of the company’s stock worth $94,208,000 after acquiring an additional 158,501 shares during the period. 88.00% of the stock is owned by institutional investors.

Cardinal Health (NYSE CAH) traded up $0.09 during trading hours on Monday, hitting $66.72. 4,354,478 shares of the stock traded hands, compared to its average volume of 3,180,000. Cardinal Health has a 12-month low of $54.66 and a 12-month high of $84.88. The company has a debt-to-equity ratio of 1.19, a quick ratio of 0.52 and a current ratio of 1.09. The stock has a market cap of $21,020.00, a PE ratio of 11.60, a price-to-earnings-growth ratio of 1.45 and a beta of 0.95.

Cardinal Health declared that its Board of Directors has initiated a share repurchase plan on Thursday, February 8th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the company to repurchase shares of its stock through open market purchases. Shares buyback plans are generally an indication that the company’s board of directors believes its stock is undervalued.

The firm also recently declared a quarterly dividend, which will be paid on Sunday, April 15th. Investors of record on Monday, April 2nd will be given a dividend of $0.4624 per share. The ex-dividend date is Thursday, March 29th. This represents a $1.85 dividend on an annualized basis and a yield of 2.77%. Cardinal Health’s dividend payout ratio (DPR) is currently 32.17%.

TRADEMARK VIOLATION NOTICE: This piece of content was originally published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this piece of content can be accessed at https://theolympiareport.com/2018/02/10/1-58-eps-expected-for-cardinal-health-inc-cah-this-quarter.html.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Get a free copy of the Zacks research report on Cardinal Health (CAH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.